Yatharth Hospital and Trauma Care Services Limited
933.00
INR
+12.20
(+1.32%)
Yatharth Hospital and Trauma Care Services Limited
NSE:YATHARTH
(National Stock Exchange of India)
Recent
price
933.00
P/E
ratio
45.67
div
yld
- -
ROIC.AI
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.- Similar Companies
- Business
- Yatharth Hospital & Trauma Care Services Limited operates as a private for-profit hospital chain primarily in North India, specializing in multi-specialty and super-specialty healthcare services including tertiary care and trauma services. The company offers comprehensive medical treatments across product categories such as cardiology, oncology, orthopedics, nephrology, cochlear implants, women and child care, abdominal pain treatment, coronary artery disease treatment, heart bypass surgery, and trauma care. It operates eight hospitals with a combined bed capacity exceeding 2,500 beds, with facilities in Uttar Pradesh, Haryana, Madhya Pradesh, and Delhi NCR. Yatharth also offers educational programs including Diplomate of National Board (DNB) courses in various medical specialties. Founded in 2008 and headquartered in Noida, India, Yatharth Hospital & Trauma Care Services Limited has expanded through both organic growth and acquisitions. Recent major developments include the acquisition of the Faridabad-based 175-bedded Asian Fidelis Hospital in early 2024, which was expanded to 200 beds, and the strategic acquisition of a super-specialty hospital in Delhi formerly known as MD City Hospital. The company also entered into a strategic collaboration to acquire a 60% stake in a 400-bedded hospital in Faridabad, Haryana. These moves support Yatharth’s goal of doubling its bed capacity to approximately 3,000 within three years. Furthermore, it is actively investing in brownfield expansions with plans to add 200 and 250 beds at its Noida Extension and Greater Noida hospitals respectively. The company continues to introduce advanced medical technologies and services, such as robotic knee replacement surgeries and advanced cardiac interventions, reinforcing its position as a leading healthcare provider in the region. The promoter recently sold nearly a 6% stake in the company, indicating active management of its equity base. Yatharth serves a broad patient demographic across Northern India with a focus on delivering high-quality, accessible healthcare through its network of super specialty hospitals. It maintains accreditations from NABH and, notably, its Greater Noida West facility is the first in Uttar Pradesh to achieve Joint Commission International accreditation. The combination of strong organic growth, strategic acquisitions, and technological advancements positions Yatharth Hospital & Trauma Care Services Limited as a prominent player in the Indian healthcare sector.